Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F. Durif

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Drugs & Aging|July 17, 1999
Treating and preventing levodopa-induced dyskinesias: current and future strategiesF Durif
Revue Neurologique|April 15, 2003
[Motor fluctuations]F Durif
Revue Neurologique|April 25, 2007
[Do chorea and ballism constitute poles of a symptom continuum?]F Durif
Revue Neurologique|April 12, 2003
[Motor fluctuations]F. Durif
Revue Neurologique|May 30, 2003
[Dopaminergic treatment and parkinsonian syndromes]F Ghawche, F Durif
Journal of Neurology|April 17, 2002
A randomized, double-masked, crossover comparison of the efficacy and safety of botulinum toxin type A produced from the original bulk toxin source and current bulk toxin source for the treatment of cervical dystoniaM Naumann, A Yakovleff, F Durif, et al.
Journal of Neuroscience Methods|September 28, 2001
Assessment of motor behavior using a video system and a clinical rating scale in parkinsonian monkeys lesioned by MPTPC Chassain, A Eschalier, F Durif
Experimental Neurology|August 5, 2003
Antidyskinetic effect of magnesium sulfate in MPTP-lesioned monkeysC Chassain, A Eschalier, F Durif
Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1993
Apomorphine in treatment of Parkinson's disease: comparison between subcutaneous and sublingual routesD Deffond, F Durif, M Tournilhac
Journal of Neurology, Neurosurgery, and Psychiatry|December 1, 1990
Efficacy of sublingual apomorphine in Parkinson's diseaseF Durif, D Deffond, M Tournilhac
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Drugs & Aging|July 17, 1999
Treating and preventing levodopa-induced dyskinesias: current and future strategiesF Durif
Revue Neurologique|April 15, 2003
[Motor fluctuations]F Durif
Revue Neurologique|April 25, 2007
[Do chorea and ballism constitute poles of a symptom continuum?]F Durif
Revue Neurologique|April 12, 2003
[Motor fluctuations]F. Durif
Revue Neurologique|May 30, 2003
[Dopaminergic treatment and parkinsonian syndromes]F Ghawche, F Durif
Journal of Neurology|April 17, 2002
A randomized, double-masked, crossover comparison of the efficacy and safety of botulinum toxin type A produced from the original bulk toxin source and current bulk toxin source for the treatment of cervical dystoniaM Naumann, A Yakovleff, F Durif, et al.
Journal of Neuroscience Methods|September 28, 2001
Assessment of motor behavior using a video system and a clinical rating scale in parkinsonian monkeys lesioned by MPTPC Chassain, A Eschalier, F Durif
Experimental Neurology|August 5, 2003
Antidyskinetic effect of magnesium sulfate in MPTP-lesioned monkeysC Chassain, A Eschalier, F Durif
Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1993
Apomorphine in treatment of Parkinson's disease: comparison between subcutaneous and sublingual routesD Deffond, F Durif, M Tournilhac
Journal of Neurology, Neurosurgery, and Psychiatry|December 1, 1990
Efficacy of sublingual apomorphine in Parkinson's diseaseF Durif, D Deffond, M Tournilhac
Pageof 11